The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro.
Heurtault
B
B
Laboratoire de Physico-Chimie, Pharmacotechnie et Biopharmacie, UMR CNRS 8612, Université de Paris-Sud, 5 rue Jean-Baptiste Clément, 92296 Châtenay-Malabry, France.
Legrand
P
P
Mosqueira
V
V
Devissaguet
J P
JP
Barratt
G
G
Bories
C
C
D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D006224:Cricetinae; D004337:Drug Carriers; D020128:Inhibitory Concentration 50; D007893:Leishmania donovani / Q000187:drug effects*; D016014:Linear Models; D008264:Macrophages / Q000469:parasitology; D051379:Mice; D011319:Primaquine / Q000494:pharmacology*
D000981:Antiprotozoal Agents; D004337:Drug Carriers; D011319:Primaquine